Guangdong Historical Income Statement

603983 Stock

29.15 0.98 3.48%

Historical analysis of Guangdong Marubi income statement accounts such as Net Interest Income of 24.6 M, Interest Income of 25.3 M or Interest Expense of 6.2 M can show how well Guangdong Marubi Biotechnology performed in making a profits. Evaluating Guangdong Marubi income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Guangdong Marubi's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Guangdong Marubi Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Guangdong Marubi Bio is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Guangdong Marubi Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Guangdong Income Statement Analysis

Guangdong Marubi Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Guangdong Marubi shareholders. The income statement also shows Guangdong investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Guangdong Marubi Income Statement Chart

At present, Guangdong Marubi's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 24.6 M, whereas Selling General Administrative is forecasted to decline to about 798.9 M.

Total Revenue Gross Profit Operating Income Ebit Research Development Income Before Tax

Total Revenue

Total revenue comprises all receipts Guangdong Marubi Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Guangdong Marubi Biotechnology minus its cost of goods sold. It is profit before Guangdong Marubi operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Operating Income

Operating Income is the amount of profit realized from Guangdong Marubi Bio operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Guangdong Marubi Biotechnology is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Guangdong Marubi income statement and is an important metric when analyzing Guangdong Marubi Bio profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from Guangdong Marubi's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Guangdong Marubi Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Guangdong Marubi Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Net Interest Income	34.1M	14.0M	15.1M	24.6M
Tax Provision	68.4M	39.2M	39.5M	52.3M

Net Interest Income Tax Provision

Guangdong Marubi income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Ebitda	Reconciled Depreciation
Tax Provision		0.64	0.6	-0.07	0.42	0.37	0.2	0.92	0.92	0.85	0.39	0.52	0.11	0.95	0.93	0.82	0.58	0.86	-0.26
Net Interest Income	0.64		0.98	0.01	0.32	0.24	-0.1	0.37	0.41	0.34	0.41	0.47	0.19	0.45	0.41	0.56	0.36	0.46	-0.15
Interest Income	0.6	0.98		0.18	0.44	0.37	-0.24	0.3	0.36	0.31	0.54	0.58	0.34	0.41	0.37	0.6	0.25	0.36	0.0
Selling General Administrative	-0.07	0.01	0.18		0.87	0.89	-0.83	-0.25	-0.07	0.01	0.86	0.78	0.98	-0.07	-0.1	0.47	-0.62	-0.48	0.88
Total Revenue	0.42	0.32	0.44	0.87		0.99	-0.69	0.22	0.37	0.46	0.97	0.97	0.94	0.39	0.36	0.83	-0.34	-0.02	0.68
Gross Profit	0.37	0.24	0.37	0.89	0.99		-0.68	0.2	0.36	0.45	0.96	0.94	0.94	0.37	0.34	0.81	-0.38	-0.06	0.7
Other Operating Expenses	0.2	-0.1	-0.24	-0.83	-0.69	-0.68		0.47	0.37	0.18	-0.75	-0.7	-0.85	0.34	0.38	-0.29	0.65	0.62	-0.91
Operating Income	0.92	0.37	0.3	-0.25	0.22	0.2	0.47		0.97	0.91	0.13	0.26	-0.12	0.98	0.98	0.67	0.59	0.93	-0.45
Net Income From Continuing Ops	0.92	0.41	0.36	-0.07	0.37	0.36	0.37	0.97		0.92	0.27	0.39	0.05	1.0	1.0	0.76	0.48	0.87	-0.35
Ebit	0.85	0.34	0.31	0.01	0.46	0.45	0.18	0.91	0.92		0.35	0.46	0.13	0.92	0.92	0.82	0.29	0.8	-0.19
Research Development	0.39	0.41	0.54	0.86	0.97	0.96	-0.75	0.13	0.27	0.35		0.97	0.95	0.3	0.26	0.81	-0.27	-0.08	0.74
Cost Of Revenue	0.52	0.47	0.58	0.78	0.97	0.94	-0.7	0.26	0.39	0.46	0.97		0.89	0.42	0.38	0.85	-0.22	0.05	0.62
Total Operating Expenses	0.11	0.19	0.34	0.98	0.94	0.94	-0.85	-0.12	0.05	0.13	0.95	0.89		0.06	0.02	0.61	-0.52	-0.35	0.85
Income Before Tax	0.95	0.45	0.41	-0.07	0.39	0.37	0.34	0.98	1.0	0.92	0.3	0.42	0.06		1.0	0.78	0.51	0.88	-0.34
Net Income	0.93	0.41	0.37	-0.1	0.36	0.34	0.38	0.98	1.0	0.92	0.26	0.38	0.02	1.0		0.76	0.51	0.89	-0.36
Income Tax Expense	0.82	0.56	0.6	0.47	0.83	0.81	-0.29	0.67	0.76	0.82	0.81	0.85	0.61	0.78	0.76		0.12	0.5	0.27
Minority Interest	0.58	0.36	0.25	-0.62	-0.34	-0.38	0.65	0.59	0.48	0.29	-0.27	-0.22	-0.52	0.51	0.51	0.12		0.73	-0.57
Ebitda	0.86	0.46	0.36	-0.48	-0.02	-0.06	0.62	0.93	0.87	0.8	-0.08	0.05	-0.35	0.88	0.89	0.5	0.73		-0.64
Reconciled Depreciation	-0.26	-0.15	0.0	0.88	0.68	0.7	-0.91	-0.45	-0.35	-0.19	0.74	0.62	0.85	-0.34	-0.36	0.27	-0.57	-0.64

Click cells to compare fundamentals

Guangdong Marubi Account Relationship Matchups

Guangdong Marubi income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	101.2M	104.0M	68.4M	39.2M	39.5M	52.3M
Net Interest Income	22.2M	57.3M	34.1M	14.0M	15.1M	24.6M
Interest Income	22.5M	51.2M	35.5M	16.1M	21.4M	25.3M
Interest Expense	3.1M	1.1M	1.0M	1.9M	5.9M	6.2M
Selling General Administrative	631.1M	597.4M	781.1M	888.7M	1.2B	798.9M
Total Revenue	1.8B	1.7B	1.8B	1.7B	2.2B	1.8B
Gross Profit	1.2B	1.2B	1.1B	1.2B	1.6B	1.3B
Other Operating Expenses	20.9M	20.4M	18.5M	1.6M	1.4M	1.4M
Operating Income	571.4M	487.5M	250.3M	173.4M	200.4M	273.2M
Net Income From Continuing Ops	512.8M	463.4M	241.2M	167.4M	277.6M	261.9M
Ebit	411.8M	525.6M	437.9M	250.3M	287.8M	407.4M
Research Development	44.9M	50.2M	50.5M	52.9M	62.3M	47.8M
Cost Of Revenue	573.5M	589.7M	643.0M	547.3M	652.2M	594.6M
Total Operating Expenses	1.2B	1.3B	1.5B	1.6B	2.0B	1.5B
Income Before Tax	614.0M	567.4M	309.6M	206.6M	317.1M	314.1M
Net Income Applicable To Common Shares	415.3M	514.9M	464.4M	247.9M	285.1M	400.9M
Net Income	514.9M	464.4M	247.9M	174.2M	259.4M	262.0M
Income Tax Expense	74.3M	101.2M	104.0M	68.4M	78.7M	81.4M
Ebitda	629.6M	581.1M	330.7M	236.4M	212.7M	348.0M
Reconciled Depreciation	15.6M	12.6M	20.1M	26.5M	24.6M	20.2M

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

Other Information on Investing in Guangdong Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Guangdong Historical Income Statement

About Guangdong Income Statement Analysis

Guangdong Marubi Income Statement Chart

Total Revenue

Gross Profit

Operating Income

Income Before Tax

Guangdong Marubi income statement Correlations

Guangdong Marubi Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Guangdong Marubi income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Guangdong Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Income Before Tax
Gross Profit	+ 0.99	Total Revenue
Interest Income	+ 0.98	Net Interest Income
Total Operating Expenses	+ 0.98	Selling General Administrative

Reconciled Depreciation	- 0.91	Other Operating Expenses
Total Operating Expenses	- 0.85	Other Operating Expenses
Other Operating Expenses	- 0.83	Selling General Administrative
Research Development	- 0.75	Other Operating Expenses
Cost Of Revenue	- 0.7	Other Operating Expenses
Other Operating Expenses	- 0.69	Total Revenue